Results 101 to 110 of about 13,171 (198)

Precision virotherapy for IDH-mutant astrocytoma. [PDF]

Mol Ther Oncol
Panagioti E, Lawler SE, Yaffe MB, Chiocca EA, Cook CH.   +4 more
europepmc   +1 more source

Hvem siterer du? [PDF]

Tidsskrift for Den norske legeforening, 2021
openaire   +1 more source

Hvem tog livet af de store dyr?

, 2014
Når de selvstyrende biler kommer på vejene, vil de komme til at tage beslutninger, der gælder menneskers liv eller død.
Pedersen, Jens Olaf Pepke
core  

Elevated BTLA Expression Correlates with an Immunosuppressive Microenvironment and Defines Dysfunctional Circulating T Cells in Human Glioblastoma. [PDF]

Med Sci (Basel)
Souat S, El Azhary K, Bourdoukh S, Kone AS, Qandouci A, Harmak Z, Choukri K, Lakhdar A, Badou A.   +8 more
europepmc   +1 more source

Association between B and T lymphocyte attenuator/herpes virus entry mediator immunoregulatory axis and outcome prediction in a mixed critically ill population. [PDF]

Sci Rep
Kokkoris S, Theodorou E, Lotsios NS, Keskinidou C, Vrettou CS, Poupouzas G, Issaris V, Premetis I, Kotanidou A, Dimopoulou I, Vassiliou AG.   +10 more
europepmc   +1 more source

Causal Exposures of Immune Cells in Neuromyelitis Optica Spectrum Disorders: A Mendelian Randomization Study and Flow Cytometry Analysis. [PDF]

Brain Behav
Ren J, Wang J, Niu Z, Guo J, Zhang N, Hao H, Gao F, Liu R, Wang Z.   +8 more
europepmc   +1 more source

HVEM expression contributes to tumor progression and prognosis in human colorectal cancer.

Background: Herpesvirus entry mediator (HVEM) has been recently suggested to play certain roles in cancer biology. We examined HVEM expression in human colorectal cancer (CRC) to reveal its clinical importance.
Yasuda, Satoshi, Ueda, Takeshi, Koyama, Fumikazu, Nakajima, Yoshiyuki, Kawasaki, Keijiro, Sho, Masayuki, Nishigori, Naoto, Nakamura, Shinji, Obara, Shinsaku, Nakamoto, Takayuki, Fujii, Hisao, Nishiwada, Satoshi, Inoue, Takashi   +12 more
core  

ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: A single-arm, phase 1/2 study. [PDF]

Neuro Oncol
Zeng W, Wang P, Fang S, Ge S, Jia W, Peng S, Wang M, Qin X, Zhang W, Gao J, Su X, Yuan G, Wu J, Liu Y, Wang Y, Lu H, Mu R, Wu F, Chang Q, Jin G, Meng F, Zhang J, Liu F.   +22 more
europepmc   +1 more source

CD160-Derived Peptide as a Bidirectional Inhibitor Toward Immune Checkpoints BTLA/HVEM and HVEM/LIGHT. [PDF]

J Med Chem
Lipińska M, Ciura P, Gumpelmair S, Sikorska E, Kuncewicz K, Sieradzan AK, Steinberger P, Wardowska A, Spodzieja M.   +8 more
europepmc   +1 more source

Immune Checkpoint Signatures Reveal Stage-Specific Biomarkers for High-Activity Multiple Sclerosis. [PDF]

Int J Mol Sci
López-Molina M, Torres Iglesias G, Vidal L, Díaz Gamero N, Sánchez-Pascual Á, Chamorro B, Lozano-Rodríguez R, Sáenz de Santa María-Diez G, Del Prado-Montero J, López-Collazo E, Díez-Tejedor E, Laso-García F, Gutiérrez-Fernández M, Otero-Ortega L.   +13 more
europepmc   +1 more source